Professional
Added to YB: 2026-09-23
Pitch date: 2026-06-30
DIM.PA [bullish]
Sartorius Stedim Biotech S.A.
+14.22%
current return
Author Info
No bio for this author
Company Info
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
Market Cap
EUR 19.3B
Pitch Price
EUR 180.00
Price Target
N/A
Dividend
0.35%
EV/EBITDA
25.57
P/E
65.82
EV/Sales
7.15
Sector
Life Sciences Tools and Services
Category
value
Baron International Growth Fund Added On Portfolio Holding: Sartorius Stedim Biotech S.A.
DIM.PA: Sartorius Stedim is a bioprocessing leader positioned to outgrow an 8%-10% annual-growth market by 1-2 percentage points while generating approximately 30% EBITDA margins. Its scalable, single-use bioreactor lineup reduces customer capital needs and contamination risk. After a significant life-science multiple derating, an improving earnings trajectory could support a re-rating, with additional optionality when the controlling Sartorius heirs’ trust unlocks in July 2028.
Read full article (1 min)